✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Sandu Pharmaceuticals Ltd.

SANDUPHQ

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹37 Cr.
P/E
23.78

Sandu Pharmaceuticals Ltd.

  • Sandu Pharmaceutical
  • Deccan Health Care
  • Vineet Laboratories

FAQs on Sandu Pharmaceuticals Ltd. Shareprice

Sandu Pharmaceutical has given better returns compared to its competitors.
Sandu Pharmaceutical has grown at ~-15.52% over the last 3yrs while peers have grown at a median rate of -19.0%

Sandu Pharmaceutical is not expensive.
Latest PE of Sandu Pharmaceutical is 23.66, while 3 year average PE is 36.74.
Also latest EV/EBITDA of Sandu Pharmaceutical is 12.16 while 3yr average is 19.36.

View FAQ's On Business

Growth Table

  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Vineet Laboratories

Balance Sheet

  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Vineet Laboratories

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Vineet Laboratories

Cash Flow

  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Vineet Laboratories

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Vineet Laboratories

Quarterly Results

  • Sandu Pharmaceuticals Ltd.
  • Deccan Health Care
  • Vineet Laboratories

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Sandu Pharmaceuticals Ltd. Financials

Balance sheet of Sandu Pharmaceutical is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Sandu Pharmaceutical is decreasing.
Latest net debt of Sandu Pharmaceutical is -₹5.27 Crs as of Mar-25.
This is less than Mar-24 when it was -₹2.38 Crs.

The profit is oscillating.
The profit of Sandu Pharmaceutical is ₹1.55 Crs for Mar 2025, ₹1.46 Crs for Mar 2024 and ₹1.52 Crs for Mar 2023

The company seems to pay a good stable dividend.
Sandu Pharmaceutical latest dividend payout ratio is 49.81% and 3yr average dividend payout ratio is 50.12%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech